PRKAA1 and squamous cell lung carcinoma: Patient tumor samples, including lung squamous cell carcinoma, colon adenocarcinomas, and breast invasive carcinoma tumors expressing MAGE-A3/6, have decreased AMPKα1 protein levels [23].